Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Late effects from hadron therapy.

Eleanor A Blakely1, Polly Y Chang

  • 1Life Science Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94620, USA. EABlakely@lbl.gov

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|June 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Dose Administration Schedule and Orthovoltage X-ray Beam Quality on Survival and Dose Response Relationships in C57BL/6J Mouse Models of Acute Radiation Syndrome.

Radiation research·2026
Same author

Irradiation with a mixed heavy ion beam induces ovarian follicle loss and dose-dependent mixed ovarian tumor development.

Biology of reproduction·2026
Same author

Preface to Platinum Issue of Radiation Research.

Radiation research·2025
Same author

Delayed effects of radiation exposure in a C57L/J mouse model of partial body irradiation with ~2.5% bone marrow shielding.

Frontiers in public health·2024
Same author

Ionization detail parameters and cluster dose: a mathematical model for selection of nanodosimetric quantities for use in treatment planning in charged particle radiotherapy.

Physics in medicine and biology·2023
Same author

Epithelial Responses in Radiation-Induced Lung Injury (RILI) Allow Chronic Inflammation and Fibrogenesis.

Radiation research·2023
Same journal

Definitive IMRT alone with reduced prophylactic nodal irradiation for Early-Stage Oropharyngeal Cancer: JCOG1208.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

ESTRO recommendations for the use, planning and delivery of reirradiation in locally recurrent rectal cancer - Endorsed by ASTRO.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Early ADC changes in risk-model-defined brain regions precede contrast-enhancing lesions after proton therapy for low-grade glioma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Any impact of pre-operative radiotherapy on renal function in retroperitoneal soft tissue sarcomas? A secondary ancillary analysis of the EORTC 62092 STRASS 1 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Tumor volume reduction during adaptive radiotherapy is a strong prognostic factor for oropharyngeal cancer: A retrospective multicenter study?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
See all related articles

Hadron radiotherapy offers successful cancer treatment but may cause secondary effects. Research is ongoing to understand and mitigate these late radiation effects on normal tissues.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Hadron radiotherapy, using particles like protons and carbon ions, shows promise for cancer treatment.
  • Understanding late side effects of hadron therapy is crucial due to increasing patient survival rates.
  • Limited data exists on long-term clinical effects of particle beam radiation.

Purpose of the Study:

  • To review available data on late tissue effects from particle radiation exposure.
  • To discuss the significance of these effects for the future of hadron therapy.
  • To highlight areas needing further investigation, such as low-dose effects and molecular mechanisms.

Main Methods:

  • Review of clinical data from international hadron radiotherapy programs.
  • Analysis of reported late-appearing clinical effects from proton and heavy ion therapy.

Related Experiment Videos

  • Synthesis of information on normal tissue responses to particle radiation.

    • Main Results:

    • Hadron therapy can reduce irradiated normal tissue volumes, but some tissues within treatment areas may show enhanced responses.
    • Identified late effects include secondary cancers, cataracts, fibrosis, neurodegeneration, vascular damage, and immunological, endocrine, and hereditary changes.
    • Low-dose effects at tumor margins and underlying molecular mechanisms require further study.

    Conclusions:

    • While hadron radiotherapy offers benefits, potential late effects on normal tissues must be carefully considered.
    • Continued research is essential to fully understand and manage the long-term consequences of particle radiation therapy.
    • Future studies should focus on molecular mechanisms and low-dose effects to optimize hadron therapy safety and efficacy.